Pfizer: If vaccine-escape variant emerges, expects to develop, produce new vaccine in about 100 days

Joel Frank Independent Analyst

According to vaccine-maker Pfizer, in case there was a "vaccine-escape" variant, the company expects to be able to develop and produce a new tailor-made vaccine against that variant within about 100 days.

Market Reaction

The comments from Pfizer have offered little solace to a still overall very risk-off market. 100 days for a vaccine is good, but then nations would have to roll the vaccine out, which as seen in 2021, takes many months.

A vaccine-resistant variant, if that is what the new South African variant turns out to be, could still deliver a significant blow to the global economic outlook over the next six months if nations significantly tighten lockdowns and travel restrictions and consumers begin to fear the virus again.

Author

Joel Frank

Independent Analyst

Joel Frank is an economics graduate from the University of Birmingham and has worked as a full-time financial market analyst since 2018, specialising in the coverage of how developments in the global economy impact financial asset

GBP/USD gathers strength to near 1.3300; NFP data loom

The GBP/USD pair gains traction to near 1.3290 during the Asian trading hours on Thursday. The British Pound strengthens against the US Dollar as the UK's likely next Prime Minister, Andy Burnham, has eased market concerns by pledging strict fiscal discipline. The US Nonfarm Payrolls data for June will take center stage later on Thursday.

EUR/USD approaches 1.1400 as bearish flag remains in play

The EUR/USD pair ticks higher during the Asian session though it lacks bullish conviction as traders keenly await the release of the crucial US Nonfarm Payrolls report. Spot prices currently trade around the 1.1385 area and remain close to the weekly low, touched on Wednesday.

Gold trades with positive bias; Fed hike bets cap gains ahead of US NFP

Gold attracts fresh buyers during the Asian session, following the previous day's volatile price swings and a late pullback from an over one-week high. The US Dollar edges lower on the back of Wednesday's softer-than-expected US macro data and turns out to be a key factor supporting the commodity for the second consecutive day.

Ripple and Stellar build on recovery as traders turn cautiously bullish

Ripple and Stellar extend recovery as improving market sentiment supports a rebound. XRP trades above $1.05 while XLM climbs past $0.199. Traders should remain cautious, as mixed on-chain and derivatives data indicate a modest bullish bias, and further upside may depend on sustained buying momentum.

A preview of NFP

The number is of much greater importance than usual as the Fed moves away from a forecasting framework and towards a current-data/rebuilding-credibility framework. While I have been pooh-poohing Warsh’s hawkish opener, I am also open to the idea that if he is serious about rebuilding credibility, he can find enough hawkish votes, and if June NFP is another hot one—July FOMC could be in play.

Just like Fed, is BoJ’s independence under threat?

When talking about central bank independence, most of the focus has been on Donald Trump’s pressure on the Federal Reserve. But a similar story, a quieter one for now, seems to be happening on the other side of the Pacific: Japan’s government may be testing the Bank of Japan’s independence.